Cite
Computational-based drug design of novel small molecules targeting p53-MDMX interaction.
MLA
Egbemhenghe, Abel Ujaigbe, et al. “Computational-Based Drug Design of Novel Small Molecules Targeting P53-MDMX Interaction.” Journal of Biomolecular Structure & Dynamics, vol. 42, no. 13, Aug. 2024, pp. 6678–87. EBSCOhost, https://doi.org/10.1080/07391102.2023.2245483.
APA
Egbemhenghe, A. U., Aderemi, O. E., Omotara, B. S., Akhimien, F. I., Osabuohien, F. O., Adedapo, H. A., Temionu, O. R., Egejuru, W. A., Ajala, C. F., Ihunanya, M. F., Oluwafemi, O. O., Onu, C. F. D., Ajibare, A. C., Ddamulira, C., Abalum, J. O., & Afolayan, O. M. (2024). Computational-based drug design of novel small molecules targeting p53-MDMX interaction. Journal of Biomolecular Structure & Dynamics, 42(13), 6678–6687. https://doi.org/10.1080/07391102.2023.2245483
Chicago
Egbemhenghe, Abel Ujaigbe, Olajide Enoch Aderemi, Bamidele Samson Omotara, Faith Iyayi Akhimien, Faith Osaretin Osabuohien, Habeebulah Ajibola Adedapo, Oluwakemi Rita Temionu, et al. 2024. “Computational-Based Drug Design of Novel Small Molecules Targeting P53-MDMX Interaction.” Journal of Biomolecular Structure & Dynamics 42 (13): 6678–87. doi:10.1080/07391102.2023.2245483.